text: Yo, listen up, I got a story to tell,
  'Bout the struggle with HNSCC, it's a living hell.
  Radioresistance, the biggest hurdle we face,
  But we found a solution, let me show you the case.
  
  We discovered a combo, a real game-changer,
  Radiotherapy with statins, a powerful behavior.
  Mevalonate pathway inhibitors, that's the key,
  They can overcome the resistance, set us free.
  
  Proteomic profiling gave us the insight,
  The mevalonate biosynthetic pathway in our sight.
  Comparing the radioresistant to radiosensitive,
  Showed the difference, now we're getting inventive.
  
  Pitavastatin, a mevalonate pathway foe,
  When combined with radiation, it puts on a show.
  Sensitizing SQ20B cells, making 'em weak,
  Reducing their clonogenic potential, so to speak.
  
  This study's a game-changer, it's quite profound,
  The mevalonate pathway, a target we found.
  In radioresistant HNSCCs, we gonna fight,
  With radiotherapy and statins, shining the light.
  
  So remember this tale, it's a promising view,
  The battle against HNSCC, we're pushing through.
  Radioresistance won't hold us back, we'll persist,
  With the mevalonate pathway, we'll cease and desist.